Acadia Pharmaceuticals | Costo Del Venduto



Cost Of Sales Cambiamento Data
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 49.2M 12.92M 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Corcept Therapeutics USD 2.96M 89K 2024-12
Cytokinetics 463K 79.14M 2024-09
Eisai JPY 45.94B 3.42B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Incyte USD 67.8M 14.58M 2025-03
J&J USD 7.3B 189M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Prothena 970K 4.78M 2024-09
PTC Therapeutics USD 16.28M 5.44M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Acadia Pharmaceuticals Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.